How do you choose the right neuromodulation strategy for a younger, active patient with mixed incontinence? Dr. Tracey Wilson (@traceywilsonmd), Dr. Kenneth Peters (@KennethMPeters1) , and Dr. Jannah Thompson break down a real-world case, sharing how patient needs, ankle checks, and lifestyle drive their neuromodulation choices. Access the full episode in the BackTable app: backtable.com/shows/urology/… This podcast was developed in collaboration with @sufuorg. #URO318 #SUFU #Neuromodulation #OAB #UrinaryIncontinence @BeaumontUrology @UABUrology @TrinityHealthMI @RuchikaTalwarMD

Recurrent bladder cancer is rarely as simple as treating the next tumor. Every recurrence raises a new decision: watch, treat in the office, or head back to the OR? On this episode of the BackTable Urology Podcast, Dr. Charles Peyton (@ccp1983) joins Dr. Ruchika Talwar (@RuchikaTalwarMD) to discuss the evolving management of recurrent low-grade, intermediate-risk non-muscle-invasive bladder cancer. They cover everything from office-based management and repeat TURBTs to patient-reported outcomes, recurrence patterns, and the role of newer therapies like UGN-102. Throughout the discussion, one message remains clear: caring for recurrent NMIBC isn't just about treating the next tumor. It's about understanding the patient, the disease, and the decisions that shape long-term care. 🔗 Check out the full episode → backtable.com/shows/urology/… #URO323 #BladderCancer #NMIBC #UrologicOncology #TURBT #BladderCancerAwareness @UABUrology @VUMChealth